retatrutide
Semaglutide vs Tirzepatide: How Retatrutide Dominates MC4R Results?
Retatrutide reduces body weight by up to 30% in MC4R-deficient patients, outperforming semaglutide and tirzepatide and offering a broader cardiometabolic safety window. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Semaglutide: First-Choice GLP-1